Medicine
Bupivacaine 125 mg/50 mL injection
Bupivacaine 125 mg/50 mL injection is a generic prescription medicine for infiltration, perineural use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Bupivacaine
- Brand
- Sold under the generic name
- Strength
- 125 mg/50 mL
- Dosage form
- Injection
- Route
- Infiltration, perineural
- Packs
- 1 vial of 50 mL, 25 vials of 50 mL, 10 vials of 50 mL and 14 more
- Manufacturers
- Anthea PharmaIndiaEugiaIndiaHealthFirstSomerset TherapeuticsMedical Purchasing SolutionsSportpharmHenry ScheinHikma PharmaceuticalsHospiraMeitheal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BB01 Bupivacaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 April 2005
- Identifiers
- RxCUI 1012396, 1012404, 1724786 +7DailyMed set ID a0f9a86f-fa55-4cbb-8273-5dcecd76d627, 4595c642-1869-436c-9550-8f9f255efd27, e391f807-7699-6d82-e053-2a95a90ab641 +11NDC 85766-305, 0143-9328, 51662-1592 +11Application ANDA207183, ANDA205141, NDA018304 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 50 mL in 1 vial | 83854-038-01 | Anthea PharmaIndia | 11 September 2026 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 55150-249-50 | EugiaIndia | 13 May 2016 |
| 10 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 0143-9328-10 | Hikma Pharmaceuticals | 11 February 2021 |
| 25 vial, multi-dose in 1 tray / 50 mL in 1 vial, multi-dose | 0409-1160-01 | Hospira | 30 April 2005 |
| 1 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 71288-723-52 | Meitheal Pharmaceuticals | 23 June 2023 |
| 1 vial in 1 carton / 50 mL in 1 vial | 70069-752-01 | Somerset Therapeutics | 16 May 2024 |
| 10 vial in 1 carton / 50 mL in 1 vial | 70069-752-10 | Somerset Therapeutics | 30 May 2024 |
| 25 vial in 1 carton / 50 mL in 1 vial | 70069-752-25 | Somerset Therapeutics | 27 November 2023 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 50 mL in 1 vial, multi-dose | 51662-1581-3 | HealthFirst | 10 July 2022 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 50 mL in 1 vial, multi-dose | 51662-1592-3 | HealthFirst | 13 July 2022 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 50 mL in 1 vial, multi-dose | 51662-1606-3 | HealthFirst | 1 August 2022 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 71872-7133-1 | Medical Purchasing Solutions | 30 March 2018 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 71872-7217-1 | Medical Purchasing Solutions | 16 July 2020 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 0404-9826-50 | Henry Schein | 3 December 2021 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 72603-279-25 | Northstar Rx | 16 December 2024 |
| 1 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 85766-305-01 | Sportpharm | 10 October 2026 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 85766-305-25 | Sportpharm | 10 October 2026 |
| 1 vial in 1 carton / 50 mL in 1 vial | 83270-168-01 | — | 29 January 2026 |
| 50 mL in 1 vial, multi-dose | 70594-116-01 | — | 1 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bupivacaine 125 mg/50 mL injection.
Other strengths and forms of Bupivacaine
Clinical summary
Bupivacaine is an amide local anesthetic indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. MedsAcross supplies Bupivacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BupivacaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Marcaine prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
- Exparel liposomal: European public assessment report (EPAR) · European Medicines Agency
Need Bupivacaine 125 mg/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.